Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04540952 · ClinicalTrials.gov registry record · NA

Comparison of Fluid Capture Efficiency of the Total Capture Drape Versus a Standard Drape for Hysteroscopy

A NA study, sponsored by Wake Forest University Health Sciences.

Terminated
Registry status
NA
Development phase
68
Enrollment target

NCT04540952: Clinical Trial NA study, sponsored by Wake Forest University Health Sciences.

NCT04540952 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04540952, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.

TERMINATED
Registry status
NA
Development phase
68 participants
Enrollment target

Study Summary

Safety during operative hysteroscopy requires a fluid management system to assist in gauging patient fluid absorption of media used for visualizing the uterine cavity. Serious patient complications, including hyponatremia (low serum sodium), heart failure, and pulmonary and cerebral edema, can result from over absorption of this distending medium. Failure of surgical drapes to collect unabsorbed fluid causes inaccurate determination of the hysteroscopic fluid deficit (HD) thus preventing proper risk evaluation for patient fluid overload, could prompt premature procedure terminatio, and result in hazards for the OR team. Specific Aims: 1. To perform a comparative trial of the "Total Capture" hysteroscopy drape (TCD) versus the standard drape during patient surgeries to document improved, real-time determination of patient fluid absorption. Pilot testing of a prototype design of the "Total Capture drape" versus the conventional hysteroscopy drape indicated remarkable improvement in fluid capture and accurate fluid deficit determination in a plastic pelvic model experiment. 2. To evaluate the clinical usefulness of the TCD compared to the Standard drape for hysteroscopy with the standardized metrics of: 1) the Technology Acceptance Model, and 2) The System Usability Scale. These metrics will allow us to quantitate clinical usefulness and usability of both the operating surgeons and operating room staff. The investigators hypothesize the "Total Capture" Drape design provides an accurate recorded hysteroscopic fluid deficit in real-time so that patient safety and surgical parameters are optimized. The simple design of the TCD would add a very significant improvement for patient safety and care with minimal cost for the estimated 200,000 hysteroscopies performed per year in the U.S.

Primary Outcome

Surgery duration, and average of 30 minutes was used to measure hysteroscopic fluid deficit measured by the fulid management system by subtracting the outflow volume returned to the fluid management system from the inflow volume.

Interventions

  • DEVICE Total Capture Drape
  • DEVICE Standard Hysteroscopy Drape

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2019-01-09
Est. Completion 2020-03-10
Phase NA
Wake Forest University Health Sciences

1,140 total trials

Why NCT04540952 stopped before completion

NCT04540952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Total Capture Drape is the first listed.

NCT04540952 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04540952 about?

NCT04540952 is a clinical study titled "Comparison of Fluid Capture Efficiency of the Total Capture Drape Versus a Standard Drape for Hysteroscopy". Safety during operative hysteroscopy requires a fluid management system to assist in gauging patient fluid absorption of media used for visualizing the uterine cavity. Serious patient complications, including hyponatremia (low serum sodium), heart failure, and pulmonary and cerebral edema, can resul...

What is the current status of trial NCT04540952?

This trial is currently terminated. It is a NA study. The enrollment target is 68 participants. The study started on 2019-01-09. Estimated completion is 2020-03-10.

What interventions are being tested in trial NCT04540952?

The interventions under investigation include: Total Capture Drape (DEVICE), Standard Hysteroscopy Drape (DEVICE).

Who is sponsoring clinical trial NCT04540952?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04540952's enrollment target sits among peer trials

68 1133rd of 2000 higher than 862 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02044497 · 68 participants · Phase 4

    Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients

  • NCT03779854 · 68 participants · Phase 2

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

  • NCT03821246 · 68 participants · Phase 2

    Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

  • NCT04115514 · 68 participants · Phase 2

    Treatment of ARDS With Instilled T3

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04540952, the US trial registry maintained by the National Library of Medicine. NCT04540952 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.